论文部分内容阅读
目的:评估我院围手术期患者雾化吸入的给药情况,为临床合理用药提供参考。方法:通过美康合理用药工作站调取电子病历结合手工检索,回顾性调研我院外科病区部分出院患者,评估围手术期雾化吸入给药的相关指标。结果:186例手术患者围手术期应用雾化吸入给药各病区比率63.79%～100.00%;雾化吸入应用最多的药物是盐酸氨溴索注射液、0.9%氯化钠注射液以及注射用硫酸依替米星;单次给药容量符合要求的占56.59%;单一用药和二联用药所占比例分别为31.71%和54.15%。结论:我院围手术期雾化吸入给药基本合理,但仍存在单次给药容量过大、不合理药物联用等现象。临床医师应与药师密切配合,综合评价,优化雾化吸入给药方案。
Objective: To evaluate the administration of nebulized inhalation in perioperative patients in our hospital and provide a reference for clinical rational drug use. Methods: We retrieved electronic medical record and hand searched by Meikang rational drug workstation and retrospectively investigated some discharged patients in surgical ward of our hospital to evaluate the related indexes of perioperative inhalation and drug administration. Results: The rate of perioperative application of aerosol inhalation in each of 186 surgical patients was 63.79% -100.00%. Ambroxol hydrochloride injection, 0.9% sodium chloride injection and injection Etirm-Sulfate; 56.59% of the single administration capacity meets the requirements; the proportions of single-agent and dual-use drugs were 31.71% and 54.15% respectively. Conclusion: Perioperative inhalation of perioperative administration is reasonable, but there is still a single administration capacity is too large, unreasonable drug combination and so on. Clinicians should work closely with pharmacists, comprehensive evaluation, optimization of inhalation drug delivery program.